Sysmex Inostics presents data at ASCO showing HPV-SEQ, a new CLIA-validated SafeSEQ NGS HPV16/18 liquid biopsy assay, is highly effective for measuring HPV DNA in the plasma of patients with oropharyngeal squamous cell carcinoma (OPSCC) enrolled in the OPTIMA 2 treatment de-escalation trial
BALTIMORE, Md., June 2, 2021 /PRNewswire/ -- Sysmex Inostics, Inc., a global leader in the liquid biopsy revolution for oncology, is...